Myriad Genetics, Inc.

NasdaqGS:MYGN Stok Raporu

Piyasa değeri: US$1.4b

Myriad Genetics Yönetim

Yönetim kriter kontrolleri 2/4

Myriad Genetics CEO'su Paul Diaz, Aug2020 tarihinde atandı, in görev süresi 4.25 yıldır. in toplam yıllık tazminatı $ 12.11M olup, şirket hissesi ve opsiyonları dahil olmak üzere 9% maaş ve 91% ikramiyelerden oluşmaktadır. şirketin hisselerinin 0.44% ine doğrudan sahiptir ve bu hisseler $ 6.19M değerindedir. Yönetim ekibinin ve yönetim kurulunun ortalama görev süresi sırasıyla 2.4 yıl ve 4.8 yıldır.

Anahtar bilgiler

Paul Diaz

İcra Kurulu Başkanı

US$12.1m

Toplam tazminat

CEO maaş yüzdesi9.0%
CEO görev süresi4.3yrs
CEO sahipliği0.4%
Yönetim ortalama görev süresi2.4yrs
Yönetim Kurulu ortalama görev süresi4.8yrs

Son yönetim güncellemeleri

Recent updates

Myriad Genetics, Inc. (NASDAQ:MYGN) Just Reported Earnings, And Analysts Cut Their Target Price

Nov 13
Myriad Genetics, Inc. (NASDAQ:MYGN) Just Reported Earnings, And Analysts Cut Their Target Price

Is Myriad Genetics (NASDAQ:MYGN) A Risky Investment?

Nov 02
Is Myriad Genetics (NASDAQ:MYGN) A Risky Investment?

Why Investors Shouldn't Be Surprised By Myriad Genetics, Inc.'s (NASDAQ:MYGN) 33% Share Price Plunge

Nov 02
Why Investors Shouldn't Be Surprised By Myriad Genetics, Inc.'s (NASDAQ:MYGN) 33% Share Price Plunge

Is Myriad Genetics, Inc. (NASDAQ:MYGN) Trading At A 31% Discount?

Sep 20
Is Myriad Genetics, Inc. (NASDAQ:MYGN) Trading At A 31% Discount?

Myriad Genetics, Inc.'s (NASDAQ:MYGN) Price Is Right But Growth Is Lacking

Aug 30
Myriad Genetics, Inc.'s (NASDAQ:MYGN) Price Is Right But Growth Is Lacking

Is Myriad Genetics (NASDAQ:MYGN) Weighed On By Its Debt Load?

Jul 17
Is Myriad Genetics (NASDAQ:MYGN) Weighed On By Its Debt Load?

Is Myriad Genetics, Inc. (NASDAQ:MYGN) Trading At A 33% Discount?

Jun 05
Is Myriad Genetics, Inc. (NASDAQ:MYGN) Trading At A 33% Discount?

Myriad Genetics, Inc.'s (NASDAQ:MYGN) Price Is Right But Growth Is Lacking After Shares Rocket 26%

May 11
Myriad Genetics, Inc.'s (NASDAQ:MYGN) Price Is Right But Growth Is Lacking After Shares Rocket 26%

Analysts Have Made A Financial Statement On Myriad Genetics, Inc.'s (NASDAQ:MYGN) First-Quarter Report

May 09
Analysts Have Made A Financial Statement On Myriad Genetics, Inc.'s (NASDAQ:MYGN) First-Quarter Report

Does Myriad Genetics (NASDAQ:MYGN) Have A Healthy Balance Sheet?

Mar 28
Does Myriad Genetics (NASDAQ:MYGN) Have A Healthy Balance Sheet?

An Intrinsic Calculation For Myriad Genetics, Inc. (NASDAQ:MYGN) Suggests It's 37% Undervalued

Feb 02
An Intrinsic Calculation For Myriad Genetics, Inc. (NASDAQ:MYGN) Suggests It's 37% Undervalued

Myriad Genetics' Strategic Growth Fuels Bullish Outlook

Jan 31

Revenues Working Against Myriad Genetics, Inc.'s (NASDAQ:MYGN) Share Price

Dec 18
Revenues Working Against Myriad Genetics, Inc.'s (NASDAQ:MYGN) Share Price

Is Myriad Genetics (NASDAQ:MYGN) Using Debt Sensibly?

Aug 07
Is Myriad Genetics (NASDAQ:MYGN) Using Debt Sensibly?

Calculating The Intrinsic Value Of Myriad Genetics, Inc. (NASDAQ:MYGN)

Apr 13
Calculating The Intrinsic Value Of Myriad Genetics, Inc. (NASDAQ:MYGN)

CEO Tazminat Analizi

Paul Diaz'un ücretlendirmesi Myriad Genetics'un kazancına kıyasla nasıl değişti?
TarihToplam TazminatMaaşŞirket Kazançları
Sep 30 2024n/an/a

-US$116m

Jun 30 2024n/an/a

-US$155m

Mar 31 2024n/an/a

-US$235m

Dec 31 2023US$12mUS$1m

-US$263m

Sep 30 2023n/an/a

-US$274m

Jun 30 2023n/an/a

-US$248m

Mar 31 2023n/an/a

-US$146m

Dec 31 2022US$11mUS$1m

-US$112m

Sep 30 2022n/an/a

-US$77m

Jun 30 2022n/an/a

-US$18m

Mar 31 2022n/an/a

-US$8m

Dec 31 2021US$13mUS$1m

-US$27m

Sep 30 2021n/an/a

-US$57m

Jun 30 2021n/an/a

-US$97m

Mar 31 2021n/an/a

-US$148m

Dec 31 2020US$16mUS$383k

-US$224m

Tazminat ve Piyasa: Paul 'nin toplam tazminatı ($USD 12.11M ), US pazarındaki benzer büyüklükteki şirketler için ortalamanın üzerindedir ($USD 5.50M ).

Tazminat ve Kazançlar: Paul şirketinin tazminatı, şirket kârsız olduğu sürece artırıldı.

CEO

Paul Diaz (62 yo)

4.3yrs

Görev süresi

US$12,108,359

Tazminat

Mr. Paul J. Diaz serves as the Member of Advisory Board at Thornton Capital, LLC. He has been the Chief Executive Officer, President and Director of Myriad Genetics, Inc. since August 13, 2020. He serves a...

Liderlik Ekibi

İsimPozisyonGörev süresiTazminatSahiplik
Paul Diaz
CEO, President & Director4.3yrsUS$12.11m0.44%
$ 6.2m
Samraat Raha
Chief Operating Officerless than a yearUS$5.02mVeri yok
Dale Muzzey
Chief Scientific Officer2.8yrsUS$2.23m0.12%
$ 1.7m
Mark Verratti
Chief Commercial Officer7.3yrsUS$2.88m0.32%
$ 4.5m
Scott Leffler
Chief Financial Officerless than a yearVeri yokVeri yok
Natalie Munk
Principal Accounting Officer2.4yrsVeri yok0.048%
$ 670.1k
Kevin Haas
Chief Technology Officer3.8yrsUS$1.64m0.14%
$ 2.0m
Matthew Scalo
Senior Vice President of Investor Relationsno dataVeri yokVeri yok
Jennifer Fox
Chief Legal Officerless than a yearVeri yokVeri yok
Glenn Farrell
Senior VP & Chief Marketing Officer1.9yrsVeri yokVeri yok
Shereen Solaiman
Chief People Officer1.7yrsVeri yok0.0031%
$ 44.3k
Patrick Burke
Executive Vice President of Strategy & Innovation3.5yrsVeri yokVeri yok

2.4yrs

Ortalama Görev Süresi

51yo

Ortalama Yaş

Deneyimli Yönetim: MYGN 'un yönetim ekibi deneyimli olarak değerlendirilmektedir (ortalama görev süresi 2.4 yıldır).

Yönetim Kurulu Üyeleri

İsimPozisyonGörev süresiTazminatSahiplik
Paul Diaz
CEO, President & Director4.3yrsUS$12.11m0.44%
$ 6.2m
Paul Bisaro
Independent Director2.1yrsUS$258.48k0.027%
$ 378.8k
Lee Newcomer
Independent Director5.2yrsUS$447.99k0.073%
$ 1.0m
Daniel Skovronsky
Independent Director4.3yrsUS$433.49k0.077%
$ 1.1m
Colleen Reitan
Independent Director5.2yrsUS$443.49k0.029%
$ 415.7k
Heinrich Dreismann
Independent Director14.4yrsUS$443.49k0.12%
$ 1.6m
S. Phanstiel
Independent Chair of the Board15.2yrsUS$563.49k0.16%
$ 2.2m
Rashmi Kumar
Independent Director4.2yrsUS$433.49k0.068%
$ 955.6k

4.8yrs

Ortalama Görev Süresi

63.5yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: MYGN 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 4.8 yıldır).